Effect of Sublingual Fentanyl on Breathlessness in COPD

NCT04004117 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
40
Enrollment
OTHER
Sponsor class

Stopped Clinical trial discontinued for reason pertaining to lack of efficacy.

Conditions

Interventions

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Collaborators